Citrus Bergamot Blood Pressure Randomized Trial: What the Evidence Says
Citrus Bergamot Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first
Quick Answer
Citrus Bergamot Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 randomized trial, 1 narrative review.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Citrus Bergamot Blood Pressure Randomized Trial: What the Evidence Says
Quick Answer
Citrus Bergamot Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Essential Oil-enhanced digital hypnotherapy for subclinical generalized anxiety: a study protocol for a randomized controlled trial | randomized trial | 2 | 2026-04-17 | 10.3389/fdgth.2026.1799921 |
| Nature’s Bioactives in Cardiorenal Syndrome: Polyphenols at the Crossroads—Preclinical Insights into Redox, Inflammation, and Mitochondrial Protection | narrative review | 3 | 2026-03-18 | 10.3390/nu18060955 |
What The Sources Report
- This physiological shift under hypnosis is associated with relaxation and could potentially be cardioprotective. [Ngandeu Schepanski Steven (2026); evidence level 2]
- For example, inhalation of lavender essential oil has repeatedly been found to reduce stress and anxiety and improve mood in various populations (-). [Ngandeu Schepanski Steven (2026); evidence level 2]
- Epidemiological studies indicate that CRS affects a substantial proportion of patients, with an estimated prevalence of up to 0.4% in the general population and 2-3% in individuals with diabetes and heart failure, and is associated with increased morbidity and mortality. [Carollo Caterina (2026); evidence level 3]
- Most preclinical studies investigating polyphenolic interventions have focused on type IV and type V CRS, particularly diabetes-induced chronic kidney disease with associated cardiovascular dysfunction. [Carollo Caterina (2026); evidence level 3]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is trial evidence in the current set, but population and intervention details still matter. For citrus bergamot blood pressure randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Ngandeu Schepanski Steven (2026). Essential Oil-enhanced digital hypnotherapy for subclinical generalized anxiety: a study protocol for a randomized controlled trial. DOI: 10.3389/fdgth.2026.1799921. PMCID: PMC13133025. PMID: 42078180. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13133025/
- Carollo Caterina (2026). Nature’s Bioactives in Cardiorenal Syndrome: Polyphenols at the Crossroads—Preclinical Insights into Redox, Inflammation, and Mitochondrial Protection. DOI: 10.3390/nu18060955. PMCID: PMC13028789. PMID: 41901130. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13028789/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed July 28, 2026 by Migaku Evidence Review
